Post-approval studies (Phase 4)Study completedNCT00327418
What this trial is testing
CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
Who this might be right for
Major Coronary EventCerebrovascular AccidentCoronary Artery Bypass Graft+2 more
Pfizer 2,800